Fatal rituximab‐associated lung injury syndrome in a patient treated with rituximab for recurrence of post‐transplant nephrotic syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|19|5|E115-E120

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.19, Iss.5, 2015-08, pp. : E115-E120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Shrinking Lung Syndrome Successfully Treated with Rituximab and Cyclophosphamide

By  

Respiration, Vol. 84, Iss. 2, 2012-01 ,pp. : 144-149

Karger

Access to resources Recommend Favorite

A Unique Case of Rituximab‐Related Posterior Reversible Encephalopathy Syndrome in a Heart Transplant Recipient With Posttransplant Lymphoproliferative Disorder

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 3, 2015-03 ,pp. : 823-826

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B‐cells

By  

NEPHROLOGY, Vol. 20, Iss. 9, 2015-09 ,pp. : 667-668

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab and Cytokine Release Syndrome

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-03 ,pp. : 134-140

Karger

Access to resources Recommend Favorite

Successful treatment of intraocular post‐transplant lymphoproliferative disorder with intravenous rituximab

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 169-172

John Wiley & Sons Inc

Access to resources Recommend Favorite